NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/01/2025
Voltar para busca
Dado oficial do USPTO
SANGUINE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
07/01/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
21/07/2023
Data de registro
07/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/01/2025
Última transação
07/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
2010-00-00
Primeiro uso no comércio
2010-00-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Woburn, MA
Examinador
SHANOSKI, JOANNA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Sanguine Biosciences, Inc.
Representantes
Elizabeth Oliner OLINER LAW
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Research laboratory analysis of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research. Research laboratory services providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research. Compiling data for research purposes in the field of medical science and medical consultancy. Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications. Providing an online searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes. Providing an online searchable database in the field of biospecimen and data collection for scientific research purposes. Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications. Providing information on the subject of scientific research in the field of biochemistry and biotechnology. Scientific laboratory services. Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications. Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research. Providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/11/2024
PUBO
PUBLISHED FOR OPPOSITION
19/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2024
RTTP
RESTORE TO TEAS PLUS
08/10/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
26/09/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/09/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
26/09/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
29/08/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/07/2024
GNFR
FINAL REFUSAL E-MAILED
02/07/2024
CNFR
FINAL REFUSAL WRITTEN
02/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/03/2024
GNRT
NON-FINAL ACTION E-MAILED
25/03/2024
CNRT
NON-FINAL ACTION WRITTEN
25/03/2024
RFTP
REMOVED FROM TEAS PLUS
25/03/2024
DOCK
ASSIGNED TO EXAMINER
25/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/08/2023
NWAP
NEW APPLICATION ENTERED
25/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SANGUINE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.